Fecal transplant is as effective and safe in immunocompromised as non-immunocompromised patients for Clostridium difficile.

Mandalia, Amar; Ward, Angela; Tauxe, William; Kraft, Colleen S; Dhere, Tanvi

Mandalia, Amar; Ward, Angela; Tauxe, William; Kraft, Colleen S; Dhere, Tanvi.

Afiliação

Mandalia A; Emory University School of Medicine, Atlanta, GA, USA.
Ward A; Division of Digestive Diseases, Emory University School of Medicine, Atlanta, GA, USA.
Tauxe W; Emory University School of Medicine, Atlanta, GA, USA.
Kraft CS; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Dhere T; Division of Digestive Diseases, Emory University School of Medicine, Atlanta, GA, USA. tdhere@emory.edu.

Int J Colorectal Dis ; 31(5): 1059-1060, 2016 May.

Article em En | MEDLINE | ID: mdl-26410257

Assuntos

Clostridioides difficile/fisiologia; Enterocolite Pseudomembranosa/terapia; Transplante de Microbiota Fecal; Hospedeiro Imunocomprometido; Transplante de Microbiota Fecal/efeitos adversos; Seguimentos; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google